Literature DB >> 28968230

Comparative evaluation of the electrophysiological, functional and ultrastructural effects of alpha lipoic acid and cyanocobalamin administration in a rat model of sciatic nerve injury.

Bahriye Horasanli1, Askin Esen Hasturk2, Murat Arikan3, Guray Togral3, Fatma Helvacioglu4, Atilla Dagdeviren4, Senem Mut5, Ferhat Harman6, Guldeniz Argun7.   

Abstract

BACKGROUND: Vitamin B12 and alpha lipoic acid (ALA) are known to promote functional and morphological recovery after peripheral nerve injury.
OBJECTIVE: To compare the regenerative and neuroprotective effects of vitamin B12 and ALA treatment after sciatic nerve injury.
METHODS: A total of 40 rats were randomly assigned to control (sciatic nerve exposure without injury or anastomosis), sham (sciatic nerve injury and epineural anastomosis were performed but no treatment was administered), PS (isotonic saline was administered for 12 weeks after surgery), ALA (2 mg/kg ALA was administered for 12 weeks after surgery), and vitamin B12 groups (2 mg/kg cyanocobalamin was administered for 12 weeks after surgery). Functional recovery was determined by footprint analysis, in vivo neurophysiology, and ex vivo histopathological examination.
RESULTS: ALA treatment produced significant improvements in sciatic functional index values and non-significant improvements on electroneuromyography compared to vitamin B12 treatment. Upon histopathological examination, the regenerative effects of ALA were relevant to axonal structural recovery whereas vitamin B12 produced greater improvements in edema and myelination.
CONCLUSIONS: While both vitamin B12 and ALA produced improvements after sciatic nerve injury, ALA was more functionally effective. The unique ultrastructural effects of vitamin B12 and ALA treatment should be considered in future studies.

Entities:  

Keywords:  Alpha lipoic acid; cyanocobalamin; electroneuromyography; nerve regeneration; neuroprotection; sciatic nerve injury

Mesh:

Substances:

Year:  2017        PMID: 28968230     DOI: 10.3233/BMR-150386

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  7 in total

Review 1.  The Impact of Supplements on Recovery After Peripheral Nerve Injury: A Review of the Literature.

Authors:  Yasmine Abushukur; Rebecca Knackstedt
Journal:  Cureus       Date:  2022-05-19

2.  Non-thermal plasma application enhances the recovery of transected sciatic nerves in rats.

Authors:  Sung-Tak Lee; Yoon-Seo Jang; Uk-Kyu Kim; Hyung-Joon Kim; Mi-Heon Ryu; Gyoo-Cheon Kim; Dae-Seok Hwang
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-02

3.  Electroacupuncture and moxibustion promote regeneration of injured sciatic nerve through Schwann cell proliferation and nerve growth factor secretion.

Authors:  Lin-Na Hu; Jin-Xin Tian; Wei Gao; Jing Zhu; Fang-Fang Mou; Xiao-Chun Ye; Yu-Pu Liu; Ping-Ping Lu; Shui-Jin Shao; Hai-Dong Guo
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

4.  Saikosaponin a increases interleukin-10 expression and inhibits scar formation after sciatic nerve injury.

Authors:  Meng-Qiang Huang; Xiao-Yu Cao; Xu-Yi Chen; Ying-Fu Liu; Shuang-Long Zhu; Zhong-Lei Sun; Xian-Bin Kong; Jing-Rui Huo; Sai Zhang; Yun-Qiang Xu
Journal:  Neural Regen Res       Date:  2018-09       Impact factor: 5.135

5.  Verification of neuroprotective effects of alpha-lipoic acid on chronic neuropathic pain in a chronic constriction injury rat model.

Authors:  Junhao Wang; Zhaohui Lou; Haiyang Xi; Zhi Li; Lepeng Li; Zhenzhen Li; Kai Zhang; Tetsuya Asakawa
Journal:  Open Life Sci       Date:  2021-03-12       Impact factor: 0.938

Review 6.  The Role of Neurotropic B Vitamins in Nerve Regeneration.

Authors:  Simone Baltrusch
Journal:  Biomed Res Int       Date:  2021-07-13       Impact factor: 3.411

7.  Non-thermal plasma accelerates the healing process of peripheral nerve crush injury in rats.

Authors:  Hyeong-Geun Lee; Jeong-Hae Choi; Yoon-Seo Jang; Uk-Kyu Kim; Gyoo-Cheon Kim; Dae-Seok Hwang
Journal:  Int J Med Sci       Date:  2020-04-27       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.